Financials
- Market Capitalization 135.51 M
- Employee 48
- Founded 2015
- CEO N/A
- Website www.alxoncology.com
- Headquarter Delaware, United States
- FIGI BBG00VR8SDG8
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.59
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3714 | AVXL Anavex Life Sciences Corp. - Common Stock | 1.48 USD | -1.99% | -5.73% | -43.30% | -82.75% | 137.19 M USD | ||
| 3718 | ANTX AN2 Therapeutics, Inc. - Common Stock | 3.60 USD | -16.28% | -28.29% | -33.70% | +183.46% | 135.85 M USD | ||
| 3735 | RNA Atrium Therapeutics, Inc. - Common Stock | 7.75 USD | -5.60% | -2.52% | -25.27% | -88.98% | 132.57 M USD | ||
| 3736 | VYGR Voyager Therapeutics, Inc. - Common Stock | 2.15 USD | -5.29% | -11.89% | -32.18% | -53.76% | 132.48 M USD |